Martin Shkreli’s Congressional Hearing Appearance Did Not Gain Him Any New Fans

Just try to count the smirks.

Martin Shkreli, a.k.a. "Pharma Bro," a.k.a. the former hedge-fund CEO whose pharmaceutical company angered many after dramatically raising the price of a life-saving AIDS drug—appeared at a congressional hearing on drug price increases Wednesday, but frustrated many with his unwillingness to cooperate.

Shkreli, who frequently invoked his Fifth Amendment privilege against self-incrimination, refused to answer any questions pertaining to his raising the price of Daraprim from $13.50 to $750 a pill. Shkreli, already the target of peoples’ ire over what they consider his unconscionable greediness, delivered a performance that has ignited a new round of outrage. Besides refusing to answer the majority of Rep. Trey Gowdy’s questions, Shkreli frequently smirked, his general demeanor best described as arrogant.

For instance, here's a supercut that YouTuber TacoBurritoLegend compiled of every one of Shkreli's smirks, set to music.

Outrageously high drug prices are a serious problem, one that can’t be pinned entirely on a single individual. To learn more about the issue, check out this article detailing how, in 2015, drug prices jumped by more than 10 percent. And to get an idea of how much Big Pharma spends on lobbying, click here.


Childbirth is the number one reason American women visit the hospital, and it ain't cheap. In fact, it's getting more and more expensive. A new study published in Health Affairs found that the cost of having a baby with employer-sponsored health insurance increased by almost 50% in the past seven years.

The study evaluated "trends in cost-sharing for maternity care for women with employer-based health insurance plans, before and after the Affordable Care Act," which was signed into law in 2010. The study looked at over 657,061 women enrolled in large employer-sponsored health insurance plans who delivered babies between 2008 and 2015, as these plans tend to cover more than plans purchased by small businesses or individuals.

Keep Reading

Cancer is still the second leading cause of death after heart disease for both men and women. The American Cancer Society predicts that 2020 will bring almost 1.8 million new cancer cases and 600,000 cancer deaths, but there's also some good news. The American Cancer Society recently published a report in CA: A Cancer Journal for Clinicians stating the U.S. cancer death rates experienced the largest-single year decline ever reported.

Between 2016 and 2017, cancer death rates fell by 2.2%. While cancer death rates have been steadily falling over the past three decades, it's normally by 1.5% a year. Cancer death rates have dropped by 29% since 1991, which means that there have been 2.9 million fewer cancer deaths in the past three decades than there would have been if the mortality rate had remained constant.

Keep Reading

In order to celebrate the New York Public Library's 125th anniversary, the library announced a list of the top 10 most checked out books in the library's history. The list, which took six months to compile, was determined by a team of experts who looked at the "historic checkout and circulation data" for all formats of the book. Ezra Jack Keats's "The Snow Day" tops the list, having been checked out 485,583 times through June 2019. While many children's books topped the top 10 list, the number one choice is significant because the main character of the story is black. "It's even more amazing that the top-ranked book is a book that has that element of diversity," New York Public Library President Anthony W. Marx said.

Keep Reading